Proteus vulgaris: Difference between revisions

(Created page with "==Background== ==Antibiotic Sensitivities<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== {| class="wikitable" | align="center" style="background:#f0f0f0;"|'''Cat...")
 
 
Line 17: Line 17:
| ||[[Cloxacillin]]/[[Diclox.]]||R
| ||[[Cloxacillin]]/[[Diclox.]]||R
|-
|-
| Amino-[[Penicillins]]||[[AMP]]/[[Amox]]||'''S'''
| Amino-[[Penicillins]]||[[AMP]]/[[Amox]]||R
|-
|-
| ||[[Amox-Clav]]||'''S'''
| ||[[Amox-Clav]]||'''S'''
Line 51: Line 51:
| ||[[Moxifloxacin]]||'''S'''
| ||[[Moxifloxacin]]||'''S'''
|-
|-
| ||[[Gemifloxacin]]||X1
| ||[[Gemifloxacin]]||'''S'''
|-
|-
| ||[[Gatifloxacin]]||'''S'''
| ||[[Gatifloxacin]]||'''S'''
|-
|-
| 1st G [[Cephalo]]||[[Cefazolin]]||'''S'''
| 1st G [[Cephalo]]||[[Cefazolin]]||R
|-
|-
| 2nd G. [[Cephalo]]||[[Cefotetan]]||'''S'''
| 2nd G. [[Cephalo]]||[[Cefotetan]]||'''S'''
Line 75: Line 75:
| ||[[Cefepime]]||'''S'''
| ||[[Cefepime]]||'''S'''
|-
|-
| Oral 1st G. [[Cephalo]]||[[Cefadroxil]]||'''S'''
| Oral 1st G. [[Cephalo]]||[[Cefadroxil]]||R
|-
|-
| ||[[Cephalexin]]||'''S'''
| ||[[Cephalexin]]||R
|-
|-
| Oral 2nd G. [[Cephalo]]||[[Cefaclor]]/[[Loracarbef]]||'''S'''
| Oral 2nd G. [[Cephalo]]||[[Cefaclor]]/[[Loracarbef]]||R
|-
|-
| ||[[Cefproxil]]||'''S'''
| ||[[Cefproxil]]||R
|-
|-
| ||[[Cefuroxime axetil]]||'''S'''
| ||[[Cefuroxime axetil]]||R
|-
|-
| Oral 3rd G. [[Cephalo]]||[[Cefixime]]||'''S'''
| Oral 3rd G. [[Cephalo]]||[[Cefixime]]||'''S'''
Line 89: Line 89:
| ||[[Ceftibuten]]||'''S'''
| ||[[Ceftibuten]]||'''S'''
|-
|-
| ||[[Cefpodox]]/[[Cefdinir]]/[[Cefditoren]]||'''S'''
| ||[[Cefpodox]]/[[Cefdinir]]/[[Cefditoren]]||I
|-
|-
| [[Aminoglycosides]]||[[Gentamicin]]||X1
| [[Aminoglycosides]]||[[Gentamicin]]||'''S'''
|-
|-
| ||[[Tobramycin]]||X1
| ||[[Tobramycin]]||'''S'''
|-
|-
| ||[[Amikacin]]||X1
| ||[[Amikacin]]||'''S'''
|-
|-
| ||[[Chloramphenicol]]||X1
| ||[[Chloramphenicol]]||I
|-
|-
| ||[[Clindamycin]]||X1
| ||[[Clindamycin]]||R
|-
|-
| [[Macrolides]]||[[Erythromycin]]||X1
| [[Macrolides]]||[[Erythromycin]]||R
|-
|-
| ||[[Azithromycin]]||X1
| ||[[Azithromycin]]||R
|-
|-
| ||[[Clarithromycin]]||X1
| ||[[Clarithromycin]]||R
|-
|-
| Ketolide||[[Telithromycin]]||X1
| Ketolide||[[Telithromycin]]||R
|-
|-
| Tetracyclines||[[Doxycycline]]||X1
| Tetracyclines||[[Doxycycline]]||R
|-
|-
| ||[[Minocycline]]||X1
| ||[[Minocycline]]||R
|-
|-
| Glycylcycline||[[Tigecycline]]||X1
| Glycylcycline||[[Tigecycline]]||I
|-
|-
| ||[[Daptomycin]]||X1
| ||[[Daptomycin]]||R
|-
|-
| Glyco/Lipoclycopeptides||[[Vancomycin]]||X1
| Glyco/Lipoclycopeptides||[[Vancomycin]]||R
|-
|-
| ||[[Teicoplanin]]||X1
| ||[[Teicoplanin]]||R
|-
|-
| ||[[Telavancin]]||X1
| ||[[Telavancin]]||R
|-
|-
| ||[[Fusidic Acid]]||X1
| ||[[Fusidic Acid]]||R
|-
|-
| ||[[Trimethoprim]]||X1
| ||[[Trimethoprim]]||R
|-
|-
| ||[[TMP-SMX]]||X1
| ||[[TMP-SMX]]||R
|-
|-
| Urinary Agents||[[Nitrofurantoin]]||X1
| Urinary Agents||[[Nitrofurantoin]]||R
|-
|-
| ||[[Fosfomycin]]||X1
| ||[[Fosfomycin]]||'''S'''
|-
|-
| Other||[[Rifampin]]||X1
| Other||[[Rifampin]]||R
|-
|-
| ||[[Metronidazole]]||X1
| ||[[Metronidazole]]||R
|-
|-
| ||[[Quinupristin dalfoppristin]]||X1
| ||[[Quinupristin dalfoppristin]]||X1
|-
|-
| ||[[Linezolid]]||X1
| ||[[Linezolid]]||R
|-
|-
| ||[[Colistimethate]]||X1
| ||[[Colistimethate]]||R
|}
|}


Latest revision as of 02:08, 24 June 2014

Background

Antibiotic Sensitivities[1]

Category Antibiotic Sensitivity
Penicillins Penicillin G R
Penicillin V R
Anti-Staphylocccal Penicillins Methicillin R
Nafcillin/Oxacillin R
Cloxacillin/Diclox. R
Amino-Penicillins AMP/Amox R
Amox-Clav S
AMP-Sulb S
Anti-Pseudomonal Penicillins Ticarcillin S
Ticar-Clav S
Pip-Tazo S
Piperacillin S
Carbapenems Doripenem S
Ertapenem S
Imipenem S
Meropenem S
Aztreonam S
Fluroquinolones Ciprofloxacin S
Ofloxacin S
Pefloxacin S
Levofloxacin S
Moxifloxacin S
Gemifloxacin S
Gatifloxacin S
1st G Cephalo Cefazolin R
2nd G. Cephalo Cefotetan S
Cefoxitin S
Cefuroxime S
3rd/4th G. Cephalo Cefotaxime S
Cefizoxime S
CefTRIAXone S
Ceftaroline S
CefTAZidime S
Cefepime S
Oral 1st G. Cephalo Cefadroxil R
Cephalexin R
Oral 2nd G. Cephalo Cefaclor/Loracarbef R
Cefproxil R
Cefuroxime axetil R
Oral 3rd G. Cephalo Cefixime S
Ceftibuten S
Cefpodox/Cefdinir/Cefditoren I
Aminoglycosides Gentamicin S
Tobramycin S
Amikacin S
Chloramphenicol I
Clindamycin R
Macrolides Erythromycin R
Azithromycin R
Clarithromycin R
Ketolide Telithromycin R
Tetracyclines Doxycycline R
Minocycline R
Glycylcycline Tigecycline I
Daptomycin R
Glyco/Lipoclycopeptides Vancomycin R
Teicoplanin R
Telavancin R
Fusidic Acid R
Trimethoprim R
TMP-SMX R
Urinary Agents Nitrofurantoin R
Fosfomycin S
Other Rifampin R
Metronidazole R
Quinupristin dalfoppristin X1
Linezolid R
Colistimethate R

Key

  • S susceptible/sensitive (usually)
  • I intermediate (variably susceptible/resistant)
  • R resistant (or not effective clinically)
  • S+ synergistic with cell wall antibiotics
  • U sensitive for UTI only (non systemic infection)
  • X1 no data
  • X2 active in vitro, but not used clinically
  • X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
  • X4 active in vitro, but not clinically effective for strep pneumonia

Table Overview

Gram Positives
Cocci
Clusters
Pairs/Chains
Other
Rods
Gram Negatives
Cocci
Rods
Lactose Fermenters
Lactose Non-Fermenters
Other
Rods/Cocci
Anaerobes

See Also

References

  1. ↑ Sanford Guide to Antimicrobial Therapy 2014
Retrieved from "https://www.wikem.org/w/index.php?title=Proteus_vulgaris&oldid=21940"